Author | Ben Kramer

Articles

Rituximab Update: Second Biologics, PML Risks, and More

November 25, 2014

(ACR2014) In this video interview, Genentech's Vice President for Immunology and Infectious Diseases gives the company's latest information about safe uses of the classic biologic.